Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide

Melanoma Research

Volumn 16, Issue 6, 2006, Pages 501-507

  Baldini, Patrizia M ^a   Lentini, Alessandro ^a   Mattioli, Palma ^a   Provenzano, Bruno ^a   De Vito, Paolo ^a   Vismara, Daniela ^a   Beninati, Simone ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antineoplastic agent; Atrial natriuretic peptide; Melanoma; Polyamines; Transglutaminase

Indexed keywords

ANTINEOPLASTIC AGENT; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR; POLYAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PUTRESCINE; SPERMIDINE; SPERMINE;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; ATRIAL NATRIURETIC FACTOR; CELL LINE, TUMOR; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; HUMANS; MALE; MELANINS; MELANOMA, EXPERIMENTAL; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, C-TYPE; POLYAMINES; PUTRESCINE; RATS; RATS, WISTAR; SPERMIDINE; SPERMINE; TRANSGLUTAMINASES;

EID: 33845571394     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000232296.99160.d7     Document Type: Article

References (43)

1. Brenner BM, Ballermann BJ, Gunning ME, Ziedel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70:665-669.
2. Rubattu S, Volpe M. The atrial natriuretic peptide: a changing view. J Hypertens 2001; 19:1923-1931.
3. Silberbach M, Roberts CT. Natriuretic peptide signalling. Molecular and cellular pathway to growth regulation. Cell Signal 2001; 13:221-231.
4. Cahill PA, Hassid A. Clearance receptor binding atrial natriuretic peptide inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochim Biophys Res Commun 1991; 179:1606-1613.
5. Suenobu N, Shichiri M, Iwashina M, Marmo F, Hirata Y. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Atheroscler Thromb Vasc Biol 1999; 19:140-146.
6. Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 1997; 272:14860-14866.
7. Rashed HM, Sun H, Patel D. Atrial natriuretic peptide inhibits growth of hepatoblastoma HepG2 cells means of the activation of clearance receptors. Hepatology 1993; 17:677-684.
8. Anand-Srivastava MB, Trachte GJ. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 1993; 45:455-497.
9. Zannetti A, Luly P, Musanti R, Baldini PM. Phosphatidylinositol- and phosphatidylcholine-dependent phospholipase C are involved in the mechanism of action of atrial natriuretic factor in cultured rat aortic smooth muscle cells. J Cell Physiol 1997; 170:272-278.
10. Vollmar AM, Paumgartner G, Gerbes AL. Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liver. Gut 1997; 40:145-150.
11. Vollmar AM, Schultz R. Gene expression and secretion of atrial natriuretic peptide by murine macrophages. J Clin Invest 1994; 94:539-545.
12. Vollmar AM. Influence of atrial natriuretic peptide on thymocyte development in fetal thymic organ culture. J Neuroimmunol 1997; 78:90-96.
13. Berk BC. Vascular smooth muscle growth. Autocrine growth mechanisms. Physiol Rev 2001; 81:999-1030.
14. Okawa H, Horimoto H, Mieno S, Nomura Y, Nakahara K, Yoshida M, et al. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotection through a nitric oxide-dependent mechanism. J Cardiol 2002; 39:299-304.
15. Brunner-La Rocca HP, Kiowski W, Ramsay D, Sutsch G. Therapeutic benefits of increasing atrial natriuretic peptide levels. Cardiovasc Res 2001; 51:510-520.
16. Baldini PM, De Vito P, Fraziano M, Mattioli P, Luly P, Di Nardo P. Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells. J Cell Physiol 2002; 193:103-109.
17. Baldini PM, De Vito P, Antenucci D, Vismara D, D'Aquilio F, Luly P, et al. Atrial natriuretic peptide induces cell death in human hepatoblastoma (HepG2) through the involvement of NADPH oxidase. Cell Death Differ 2004; 11:S210-S212.
18. Kiemer AK, Vollmar AM. Induction of L-arginine transport is inhibited by atrial natriuretic peptide: a peptide hormone as a novel regulator of inducible nitric-oxide synthase substrate availability. Mol Pharmacol 2001; 60:421-426.
19. Russell DH. The roles of the polyamines, putrescine, spermidine, and spermine in normal and malignant tissues. Life Sci 1973; 13:1635-1647.
20. Tabor CW, Tabor H. Polyamines. Ann Rev Biochem 1984; 53:749-790.
21. Tabor CW, Tabor H. 1,4-Diaminobutane (putrescine), spermidine and spermine. Ann Rev Biochem 1976; 45:285-306.
22. Nishida K, Abiko T, Ishihara M, Tomikawa M. Arterial injury-induced smooth muscle cell proliferation in rats is accompanied by increase in polyamine synthesis and level. Atherosclerosis 1990; 83:119-125.
23. Low BC, Ross IK, Grigor MR. Characterization of system L and system y+ amino acid transport activity in cultured vascular smooth muscle cells. J Cell Physiol 1993; 156:626-634.
24. Folk JE. Transglutaminases. Ann Rev Biochem 1980; 49:517-531.
25. Beninati S, Piacentini M. The transglutaminase family: an overview. Amino Acids 2004; 26:367-372.
26. Folk JE, Finlayson JS. The ε(γ-glutamyl)lysine crosslink and the catalytic role of transglutaminase. Adv Prot Chem 1977; 31:1-133.
27. Lentini A, Beninati S. Differentiation therapy of cancer: transglutaminase as differentiative tool. Minerva Biotechnol 2002; 14:159-164.
28. Beninati S. Transglutaminase activity and protein polyamine binding capacity in animal and plant cells. In: Pandalai G, editor. Recent developments in phytochemistry. Vol. 1. Trivandrum, India: Res Signpost; 1997. pp. 243-253.
29. Beninati S, Abbruzzese A, Cardinali M. Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells. Int J Cancer 1993; 53:792-797.
30. Beninati S. Post-translational modification of protein in cancer cells: the transglutaminase-catalyzed reactions. Cancer J 1995; 8:234-236.
31. Lentini A, Autuori F, Mattioli P, Caraglia M, Abbruzzese A, Beninati S. Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur J Cancer 2000; 36:1572-1577.
32. Facchiano F, D'Arcangelo D, Riccomi A, Lentini A, Beninati S, Capogrossi MC. Transglutaminase activity is involved in polyamine-induced programed cell death. Exp Cell Res 2001; 271:118-129.
33. Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Beninati S, Lentini A, et al. Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. J Biochem 2002; 132:45-52.
34. Lentini A, Abbruzzese A, Caraglia M, Marra M, Beninati S. Protein-polyamine conjugation by transglutaminase in cancer cell differentiation. Amino Acids 2004; 26:331-337.
35. Fidler IJ. Selection of successive tumor cell lines for metastasis. Nature (New Biol) 1973; 245:148-149.
36. Ross R. The smooth muscle cell. II. Growth of muscle in culture and formation of elastic fibers. J Cell Biol 1971; 50:171-186.
37. Chung SI, Folk JE. Transglutaminase from hair follicle of guinea pig. Proc Natl Acad Sci (Wash) 1972; 69:303-307.
38. Lotan R, Lotan D. Stimulation of melanogenesis in a human melanoma cell by retinoids. Cancer Res 1980; 40:3345-3350.
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-268.
40. Prins BA, Weber MJ, Hu RM, Pedram A, Daniels M, Levin ER. Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. J Biol Chem 1996; 271:14156-14162.
41. Durante W, Liao L, Peyton KJ, Schafer AI. Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. J Biol Chem 1997; 272:30154-30159.
42. Forgeur A, Willems F, Winand J, Robberecht P, Delporte C. Natriuretic peptide receptors of type A in human neuroblastomas. Neuroendocrinology 1999; 70:288-294.
43. Tipnis UR, Haile C, Boor PJ, Gutkowska J. Polyamine regulation of atrial natriuretic peptide in cultured cardiocytes. Reg Pept 1994; 52:75-84.